{"entity":{"id":"nct01423500","kind":"trial","name":"ALL-SCT BFM International- HSCT in Children and Adolescents With ALL","aka":[],"tldr":"A phase 3 trial of Fludarabine, Treosulfan and Thiotepa in Leukaemia, run by St. Anna Kinderkrebsforschung, with a status the registry has not verified recently.","summary":"ALL-SCT BFM International- HSCT in Children and Adolescents With ALL is a phase 3 interventional study registered as NCT01423500 by St. Anna Kinderkrebsforschung, with 405 participants planned, started 2007-01 and due to reach its primary completion in 2011-09. Interventions recorded: VP16, TBI, VP16, ATG, TBI, Fludarabine, OKT3, Treosulfan, Thiotepa, VP16, ATG, TBI. Conditions recorded: Lymphoblastic Leukemia, Acute, Childhood;.\n\nLinked to the drug Treosulfan because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01423500","url":"https://clinicaltrials.gov/study/NCT01423500"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["leukaemia"],"sections":[],"technologies":[],"targets":[],"drugs":["fludarabine","treosulfan","thiotepa"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01423500","phase":"3","setting":"Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia","sponsor":"St. Anna Kinderkrebsforschung","enrolled":405,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01423500/","neighbours":{"cancer":[{"id":"leukaemia","kind":"cancer","name":"Leukaemia (all types)","route":"/cancers/leukaemia/"}],"drug":[{"id":"fludarabine","kind":"drug","name":"Fludarabine","route":"/drugs/fludarabine/"},{"id":"thiotepa","kind":"drug","name":"Thiotepa","route":"/drugs/thiotepa/"},{"id":"treosulfan","kind":"drug","name":"Treosulfan","route":"/drugs/treosulfan/"}]}}